Preparations for phase I are largely complete. What Arcede Pharma now needs to solve is financing the upcoming study and getting a permanent CEO in place.

- At the time of writing, no such final solution has been presented, but the Board of Directors and I are working insistently on the matter, acting CEO Erik Magnusson writes in the Q1 report.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/05/full-focus-on-financing-and-new-ceo-for-arcede/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

https://news.cision.com/arcede-pharma/r/biostock--full-focus-on-financing-and-new-ceo-for-arcede,c3985644

(c) 2024 Cision. All rights reserved., source Press Releases - English